You can buy or sell REGENXBIO and other stocks, options, ETFs, and crypto commission-free!
REGENXBIO Inc. Common Stock, also called REGENXBIO, is a biotechnology company, which engages in the development, commercialization, and licensing of recombinant adeno-associated virus gene therapy. Read More The company was founded by Kennth T. Mills and James M. Wilson on July 16, 2008 and is headquartered in Rockville, MD.
52 Week High
52 Week Low
— per share
Expected May 5, After Hours